Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H6 family homeobox 2 (HMX2) is a protein-coding gene that encodes a homeobox-containing transcription factor of the NKL homeobox family, playing a critical role in embryonic development, specifically in specifying neuronal cell types and ensuring proper development of the inner ear and hypothalamus. Variants involving HMX2 have been associated with inner ear malformations, vestibular dysfunction, hearing loss, and rare syndromic developmental diseases[1][7][8]. HMX2 is not generally considered a classical drug target (such as a receptor, enzyme, ion channel, or transporter), but rather a developmental transcription factor essential for regulation of gene expression during morphogenesis. No pharmacological modulators or drugs targeting HMX2 are known or reported in major clinical resources as of the current literature. No known biomarker or safety concerns have been specifically linked to direct targeting or modulation of HMX2[1][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H6 family homeobox 2 (HMX2).